{"transactions":[{"id":4638357,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-09T01:57:45.000Z","date":"2026-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":44943,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of shares of common stock (\"Common Stock\") of BioLife Solutions, Inc. (the \"Registrant\") in connection with the consummation on October 6, 2026 of the merger of Bravo Merger Sub I, Inc., a Delaware corporation (\"Merger Sub 1\") with and into the Registrant (the \"First Merger\"), pursuant to the Agreement and Plan of Merger, dated as of July 21, 2026 (the \"Merger Agreement\"), by and among the Registrant, Repligen Corporation, a Delaware corporation (\"Repligen\"), Merger Sub 1 and Bravo Merger Sub II, LLC, a Delaware limited liability company. At the effective time of the First Merger (the \"First Merger Effective Time\"), each outstanding share of Common Stock was converted into the right to receive $11.25 in cash and 0.1442 shares of Repligen common stock, in each case subject to the terms and conditions of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-418316","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000119312526418316/ownership.xml","form_type":"4"}},{"id":880776,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-26T22:55:17.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":8170,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan and fully vests on the first anniversary of the vesting date of January 2, 2026"}],"balance_after":44943,"source":{"system":"sec-edgar","filing":"0001628280-26-012470","document":"wk-form4_1772146515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012470/wk-form4_1772146515.xml","form_type":"4"}},{"id":1123607,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T22:48:52.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":205073,"source":{"system":"sec-edgar","filing":"0000950170-25-081864","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000095017025081864/ownership.xml","form_type":"4"}},{"id":1196280,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-20T23:09:07.000Z","date":"2025-03-18","kind":"grant","planned":false,"acquired":true,"shares":6876,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan (the \"2023 Plan\") and fully vests on the first anniversary of the measurement date of 01-02-2025."}],"balance_after":36773,"source":{"system":"sec-edgar","filing":"0001628280-25-014189","document":"wk-form4_1742512140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025014189/wk-form4_1742512140.xml","form_type":"4"}},{"id":1281858,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-02-05T16:14:49.000Z","date":"2025-02-03","kind":"sale","planned":false,"acquired":false,"shares":14746,"price":1.71,"value":25215.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election\nunder its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.71 to $1.715, inclusive. The reporting person undertakes to\nprovide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with in the rage set forth above."}],"balance_after":250713,"source":{"system":"sec-edgar","filing":"0001737287-25-000018","document":"wk-form4_1738790068.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000173728725000018/wk-form4_1738790068.xml","form_type":"4"}},{"id":1488885,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T23:57:30.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":5,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":145073,"source":{"system":"sec-edgar","filing":"0001209191-24-005822","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919124005822/doc4.xml","form_type":"4"}},{"id":1536210,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"officer":true,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2024-04-24T16:18:41.000Z","date":"2024-04-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":17360,"price":3.4671,"value":60188.856,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.44 to $3.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":265459,"source":{"system":"sec-edgar","filing":"0001593968-24-000614","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000159396824000614/primary_01.xml","form_type":"4"}},{"id":1582766,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-13T01:43:36.000Z","date":"2024-03-08","kind":"grant","planned":false,"acquired":true,"shares":11264,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan (the \"2023 Plan\") and fully vests on the first anniversary of the grant date."}],"balance_after":29897,"source":{"system":"sec-edgar","filing":"0001628280-24-010744","document":"wk-form4_1710294203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024010744/wk-form4_1710294203.xml","form_type":"4"}},{"id":1665199,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"officer":true,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2024-01-31T17:51:47.000Z","date":"2024-01-25","kind":"grant","planned":false,"acquired":true,"shares":341515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the shares subject to the stock option shall vest on January 25, 2025, and the remaining shares shall vest in 24 equal monthly installments thereafter."}],"balance_after":341515,"derivative":{"exercise_price":3.2,"expiration_date":"2034-01-25","underlying":"Common Stock","underlying_shares":341515},"source":{"system":"sec-edgar","filing":"0001593968-24-000197","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000159396824000197/primary_01.xml","form_type":"4"}},{"id":1665198,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"officer":true,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2024-01-31T17:51:47.000Z","date":"2024-01-25","kind":"grant","planned":false,"acquired":true,"shares":96600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":282819,"source":{"system":"sec-edgar","filing":"0001593968-24-000197","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000159396824000197/primary_01.xml","form_type":"4"}},{"id":1750702,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-03T21:09:46.000Z","date":"2023-11-01","kind":"grant","planned":false,"acquired":true,"shares":495,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant."}],"balance_after":18633,"source":{"system":"sec-edgar","filing":"0001628280-23-036778","document":"wk-form4_1699045777.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023036778/wk-form4_1699045777.xml","form_type":"4"}},{"id":1763050,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-10T21:26:30.000Z","date":"2023-10-01","kind":"grant","planned":false,"acquired":true,"shares":362,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant."}],"balance_after":18138,"source":{"system":"sec-edgar","filing":"0001628280-23-034204","document":"wk-form4_1696973174.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023034204/wk-form4_1696973174.xml","form_type":"4"}},{"id":1861172,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-09T20:10:37.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":5,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":105073,"source":{"system":"sec-edgar","filing":"0001209191-23-035763","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919123035763/doc4.xml","form_type":"4"}},{"id":1913344,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"officer":true,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-26T17:20:45.000Z","date":"2023-04-24","kind":"grant","planned":false,"acquired":true,"shares":831024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on April 24, 2024, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":831024,"derivative":{"exercise_price":5.37,"expiration_date":"2033-04-24","underlying":"Common Stock","underlying_shares":831024},"source":{"system":"sec-edgar","filing":"0001593968-23-000643","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000159396823000643/primary_01.xml","form_type":"4"}},{"id":1913343,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"officer":true,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2023-04-26T17:20:45.000Z","date":"2023-04-24","kind":"grant","planned":false,"acquired":true,"shares":186219,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":186219,"source":{"system":"sec-edgar","filing":"0001593968-23-000643","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000159396823000643/primary_01.xml","form_type":"4"}},{"id":2053191,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-01-19T00:01:10.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":10187,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the \"Plan\") and fully vests on the first anniversary of the grant date."}],"balance_after":17776,"source":{"system":"sec-edgar","filing":"0001437749-23-001266","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923001266/rdgdoc.xml","form_type":"4"}},{"id":2166609,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-09-07T00:00:58.000Z","date":"2022-09-01","kind":"grant","acquired":true,"shares":7589,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock award was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and fully vests on the first anniversary of the grant date."}],"balance_after":7589,"source":{"system":"sec-edgar","filing":"0001437749-22-021929","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922021929/rdgdoc.xml","form_type":"4"}},{"id":2165674,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-09-06T17:41:36.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on September 6, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":750000,"derivative":{"exercise_price":5.3,"expiration_date":"2032-09-05","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001789769-22-000081","document":"wf-form4_166250048300587.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000178976922000081/wf-form4_166250048300587.xml","form_type":"4"}},{"id":2245805,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2022-06-03T21:12:23.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":39866,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest one year from the date of grant."}],"balance_after":39866,"derivative":{"exercise_price":4.84,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":39866},"source":{"system":"sec-edgar","filing":"0001209191-22-034204","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919122034204/doc4.xml","form_type":"4"}},{"id":2245804,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T21:12:23.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":20454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":65073,"source":{"system":"sec-edgar","filing":"0001209191-22-034204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919122034204/doc4.xml","form_type":"4"}},{"id":2576433,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-09-08T21:07:05.000Z","date":"2021-09-05","kind":"exercise","acquired":false,"shares":4296,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit vests in three equal annual installments beginning on anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit vests in three equal annual installments beginning on anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4296},"source":{"system":"sec-edgar","filing":"0001209191-21-055169","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919121055169/doc4.xml","form_type":"4"}},{"id":2576432,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-08T21:07:05.000Z","date":"2021-09-05","kind":"exercise","acquired":true,"shares":4296,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock."}],"balance_after":44619,"source":{"system":"sec-edgar","filing":"0001209191-21-055169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919121055169/doc4.xml","form_type":"4"}},{"id":2684280,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2021-06-04T00:02:09.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":29983,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2022 Annual Meeting of Stockholders."}],"balance_after":29983,"derivative":{"exercise_price":5.62,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":29983},"source":{"system":"sec-edgar","filing":"0001209191-21-037964","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919121037964/doc4.xml","form_type":"4"}},{"id":2684279,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-06-04T00:02:09.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"shares":13228,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of Cerus Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This RSU vested one year from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This RSU vested one year from the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":13228},"source":{"system":"sec-edgar","filing":"0001209191-21-037964","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919121037964/doc4.xml","form_type":"4"}},{"id":2684278,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-04T00:02:09.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":14888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":40323,"source":{"system":"sec-edgar","filing":"0001209191-21-037964","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919121037964/doc4.xml","form_type":"4"}},{"id":2684277,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-04T00:02:09.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":13228,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of Cerus Common Stock."}],"balance_after":25435,"source":{"system":"sec-edgar","filing":"0001209191-21-037964","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919121037964/doc4.xml","form_type":"4"}},{"id":3036759,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-09-08T21:57:21.000Z","date":"2020-09-05","kind":"exercise","acquired":false,"shares":4296,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit vests in three equal annual installments beginning on anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit vests in three equal annual installments beginning on anniversary of the date of grant."}],"balance_after":4296,"derivative":{"underlying":"Common Stock","underlying_shares":4296},"source":{"system":"sec-edgar","filing":"0001209191-20-049767","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919120049767/doc4.xml","form_type":"4"}},{"id":3036758,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-08T21:57:21.000Z","date":"2020-09-05","kind":"exercise","acquired":true,"shares":4296,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock."}],"balance_after":12207,"source":{"system":"sec-edgar","filing":"0001209191-20-049767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919120049767/doc4.xml","form_type":"4"}},{"id":3120991,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-06-05T22:50:48.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":13228,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders."}],"balance_after":13228,"derivative":{"underlying":"Common Stock","underlying_shares":13228},"source":{"system":"sec-edgar","filing":"0001209191-20-034821","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919120034821/doc4.xml","form_type":"4"}},{"id":3120990,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2020-06-05T22:50:48.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":28177,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders."}],"balance_after":28177,"derivative":{"exercise_price":6.37,"expiration_date":"2030-06-02","underlying":"Common Stock","underlying_shares":28177},"source":{"system":"sec-edgar","filing":"0001209191-20-034821","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919120034821/doc4.xml","form_type":"4"}},{"id":3274915,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-13T22:54:47.000Z","date":"2020-02-11","kind":"purchase","acquired":true,"shares":3614,"price":4.7496,"value":17165.0544,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.745 to $4.75 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the aforementioned range set forth."}],"balance_after":7911,"source":{"system":"sec-edgar","filing":"0001209191-20-009371","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919120009371/doc4.xml","form_type":"4"}},{"id":3274914,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-13T22:48:55.000Z","date":"2020-01-29","kind":"purchase","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Amending to reverse purchase transaction that did not consummate."}],"balance_after":4297,"source":{"system":"sec-edgar","filing":"0001209191-20-009369","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919120009369/doc4a.xml","form_type":"4/A","original_submission_date":"2020-02-03"}},{"id":3295300,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-04T01:21:15.000Z","date":"2020-01-29","kind":"purchase","acquired":true,"shares":3614,"price":4.15,"value":14998.1,"ownership":{"direct":true},"balance_after":7911,"source":{"system":"sec-edgar","filing":"0001209191-20-006144","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919120006144/doc4.xml","form_type":"4"}},{"id":3418783,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-09-10T19:01:49.000Z","date":"2019-09-05","kind":"exercise","acquired":false,"shares":4297,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit vests in three equal annual installments beginning on anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit vests in three equal annual installments beginning on anniversary of the date of grant."}],"balance_after":8592,"derivative":{"underlying":"Common Stock","underlying_shares":4297},"source":{"system":"sec-edgar","filing":"0001209191-19-049001","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919119049001/doc4.xml","form_type":"4"}},{"id":3418782,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-10T19:01:49.000Z","date":"2019-09-05","kind":"exercise","acquired":true,"shares":4297,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock."}],"balance_after":4297,"source":{"system":"sec-edgar","filing":"0001209191-19-049001","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919119049001/doc4.xml","form_type":"4"}},{"id":3497662,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-06-07T20:34:23.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":11184,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock unit shall vest one year from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock unit shall vest one year from the date of grant."}],"balance_after":11184,"derivative":{"underlying":"Common Stock","underlying_shares":11184},"source":{"system":"sec-edgar","filing":"0001209191-19-035556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919119035556/doc4.xml","form_type":"4"}},{"id":3497661,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2019-06-07T20:34:23.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":23703,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest one year from the date of grant."}],"balance_after":23703,"derivative":{"exercise_price":4.8,"expiration_date":"2029-06-04","underlying":"Common Stock","underlying_shares":23703},"source":{"system":"sec-edgar","filing":"0001209191-19-035556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919119035556/doc4.xml","form_type":"4"}},{"id":3822547,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-09-07T22:52:53.000Z","date":"2018-09-05","kind":"grant","acquired":true,"shares":12889,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock unit vests in three equal annual installments beginning on anniversary of the transaction date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock unit vests in three equal annual installments beginning on anniversary of the transaction date."}],"balance_after":12889,"derivative":{"underlying":"Common Stock","underlying_shares":12889},"source":{"system":"sec-edgar","filing":"0001209191-18-050143","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919118050143/doc4.xml","form_type":"4"}},{"id":3822546,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2018-09-07T22:52:53.000Z","date":"2018-09-05","kind":"grant","acquired":true,"shares":24324,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in thirty six (36) equal monthly installments on each monthly anniversary of the transaction date."}],"balance_after":24324,"derivative":{"exercise_price":7.52,"expiration_date":"2028-09-04","underlying":"Common Stock","underlying_shares":24324},"source":{"system":"sec-edgar","filing":"0001209191-18-050143","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919118050143/doc4.xml","form_type":"4"}},{"id":4191090,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-10-05T20:17:38.000Z","date":"2017-10-03","kind":"disposition_to_issuer","acquired":false,"shares":30700,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On August 27, 2017, Kite Pharma, Inc., a Delaware corporation (the \"Company\"), entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Gilead Sciences, Inc., a Delaware corporation (\"Parent\"), and Dodgers Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). On October 3, 2017, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the \"Merger\") and becoming a wholly-owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the terms of the Merger Agreement, each option to purchase Company common stock (each, a \"Company Option\") then outstanding and unexercised, other than any vested in-the-money Company Option, was assumed and converted into\nan option to purchase a number of shares of Parent common stock, on the same terms and subject to the same conditions as were applicable to such Company Option, equal to the product of (i) the total number of shares of Company common stock subject to such Company Option multiplied by (ii) the Equity Award Conversion Ratio, and with an exercise price equal to the quotient of (i) the exercise price of such Company Option divided by (ii) the Equity Award Conversion Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option provides for 25% vesting on December 22, 2017, and vesting thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":46.09,"expiration_date":"2026-12-21","underlying":"Common Stock","underlying_shares":30700},"source":{"system":"sec-edgar","filing":"0001209191-17-056223","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000120919117056223/doc4.xml","form_type":"4"}},{"id":4191089,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-10-05T20:17:38.000Z","date":"2017-10-03","kind":"disposition_to_issuer","acquired":false,"shares":96875,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On August 27, 2017, Kite Pharma, Inc., a Delaware corporation (the \"Company\"), entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Gilead Sciences, Inc., a Delaware corporation (\"Parent\"), and Dodgers Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). On October 3, 2017, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the \"Merger\") and becoming a wholly-owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the terms of the Merger Agreement, each option to purchase Company common stock (each, a \"Company Option\") then outstanding and unexercised, other than any vested in-the-money Company Option, was assumed and converted into\nan option to purchase a number of shares of Parent common stock, on the same terms and subject to the same conditions as were applicable to such Company Option, equal to the product of (i) the total number of shares of Company common stock subject to such Company Option multiplied by (ii) the Equity Award Conversion Ratio, and with an exercise price equal to the quotient of (i) the exercise price of such Company Option divided by (ii) the Equity Award Conversion Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option provided for 25% vesting on March 15, 2017, and vesting thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":44.91,"expiration_date":"2026-03-14","underlying":"Common Stock","underlying_shares":96875},"source":{"system":"sec-edgar","filing":"0001209191-17-056223","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000120919117056223/doc4.xml","form_type":"4"}},{"id":4191088,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-10-05T20:17:38.000Z","date":"2017-10-03","kind":"disposition_to_issuer","acquired":false,"shares":124125,"price":135.09,"value":16768046.25,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On August 27, 2017, Kite Pharma, Inc., a Delaware corporation (the \"Company\"), entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Gilead Sciences, Inc., a Delaware corporation (\"Parent\"), and Dodgers Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). On October 3, 2017, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the \"Merger\") and becoming a wholly-owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This vested option was cancelled at the effective time of the Merger in exchange for a cash payment equal to $180.00, less the exercise price of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option provided for 25% vesting on March 15, 2017, and vesting thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":44.91,"expiration_date":"2026-03-14","underlying":"Common Stock","underlying_shares":124125},"source":{"system":"sec-edgar","filing":"0001209191-17-056223","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000120919117056223/doc4.xml","form_type":"4"}},{"id":4191087,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Common Stock","published_at":"2017-10-05T20:17:38.000Z","date":"2017-10-03","kind":"disposition_to_issuer","acquired":false,"shares":41734,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On August 27, 2017, Kite Pharma, Inc., a Delaware corporation (the \"Company\"), entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Gilead Sciences, Inc., a Delaware corporation (\"Parent\"), and Dodgers Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). On October 3, 2017, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the \"Merger\") and becoming a wholly-owned subsidiary of Parent."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of Company common stock underlying restricted stock units with respect to Company common stock, including all time-vesting and all performance-vesting restricted stock units (each a \"Company Restricted Stock Unit\"), held by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the terms of the Merger Agreement, each Company Restricted Stock Unit was assumed and converted into a restricted stock unit denominated in shares of Parent common stock, on the same terms and conditions as were then applicable under such Company Restricted Stock Unit (including applicable performance vesting conditions), and relating to a number of shares of Parent common stock equal to the product of (i) the total number of shares of Company common stock subject to such Company Restricted Stock Unit multiplied by (ii) the quotient of (A) $180.00 divided by (B) the volume-weighted average closing sale price of a share of Parent common stock for the fifteen full consecutive trading days ending on and including September 28, 2017 ($83.12) (such quotient, the \"Equity Award Conversion Ratio\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, each Company Restricted Stock Unit was assumed and converted into a restricted stock unit denominated in shares of Parent common stock, on the same terms and conditions as were then applicable under such Company Restricted Stock Unit (including applicable performance vesting conditions), and relating to a number of shares of Parent common stock equal to the product of (i) the total number of shares of Company common stock subject to such Company Restricted Stock Unit multiplied by (ii) the quotient of (A) $180.00 divided by (B) the volume-weighted average closing sale price of a share of Parent common stock for the fifteen full consecutive trading days ending on and including September 28, 2017 ($83.12) (such quotient, the \"Equity Award Conversion Ratio\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-056223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000120919117056223/doc4.xml","form_type":"4"}},{"id":4191086,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Common Stock","published_at":"2017-10-05T20:17:38.000Z","date":"2017-10-03","kind":"other","acquired":false,"shares":3927,"price":180,"value":706860.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On August 27, 2017, Kite Pharma, Inc., a Delaware corporation (the \"Company\"), entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Gilead Sciences, Inc., a Delaware corporation (\"Parent\"), and Dodgers Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). On October 3, 2017, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the \"Merger\") and becoming a wholly-owned subsidiary of Parent."},{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of Company common stock held by the Reporting Person, other than the shares described in Notes 3 and 4 below, was validly tendered for $180 per share in cash, without interest and subject to any required withholding of taxes."}],"balance_after":41734,"source":{"system":"sec-edgar","filing":"0001209191-17-056223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000120919117056223/doc4.xml","form_type":"4"}},{"id":4200947,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Common Stock","published_at":"2017-09-27T21:42:22.000Z","date":"2017-09-25","kind":"sale","acquired":false,"shares":4228,"price":179.6639,"value":759618.9692,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU."}],"balance_after":45661,"source":{"system":"sec-edgar","filing":"0001209191-17-054198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000120919117054198/doc4.xml","form_type":"4"}},{"id":4200946,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Common Stock","published_at":"2017-09-27T21:42:22.000Z","date":"2017-09-25","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":49889,"source":{"system":"sec-edgar","filing":"0001209191-17-054198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000120919117054198/doc4.xml","form_type":"4"}},{"id":4200945,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Common Stock","published_at":"2017-09-27T21:42:22.000Z","date":"2017-03-15","kind":"sale","acquired":false,"shares":7511,"price":83.31,"value":625741.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU."}],"balance_after":41889,"source":{"system":"sec-edgar","filing":"0001209191-17-054198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000120919117054198/doc4.xml","form_type":"4"}},{"id":4242372,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-08-04T19:50:26.000Z","date":"2017-08-03","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the 155,000 shares subject to the stock option vested and became exercisable on March 15, 2017, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":146000,"derivative":{"exercise_price":44.91,"expiration_date":"2026-03-14","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-17-047796","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000120919117047796/doc4.xml","form_type":"4"}},{"id":4242371,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Common Stock","published_at":"2017-08-04T19:50:26.000Z","date":"2017-08-03","kind":"sale","acquired":false,"shares":5131,"price":110.05,"value":564666.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":49400,"source":{"system":"sec-edgar","filing":"0001209191-17-047796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000120919117047796/doc4.xml","form_type":"4"}},{"id":4242370,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Common Stock","published_at":"2017-08-04T19:50:26.000Z","date":"2017-08-03","kind":"sale","acquired":false,"shares":869,"price":110.1,"value":95676.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":54531,"source":{"system":"sec-edgar","filing":"0001209191-17-047796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000120919117047796/doc4.xml","form_type":"4"}},{"id":4242369,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Common Stock","published_at":"2017-08-04T19:50:26.000Z","date":"2017-08-03","kind":"exercise","acquired":true,"shares":6000,"price":44.91,"value":269460.0,"ownership":{"direct":true},"balance_after":55400,"source":{"system":"sec-edgar","filing":"0001209191-17-047796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000120919117047796/doc4.xml","form_type":"4"}},{"id":4243737,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-08-03T21:14:20.000Z","date":"2017-08-01","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the 155,000 shares subject to the stock option vested and became exercisable on March 15, 2017, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":152000,"derivative":{"exercise_price":44.91,"expiration_date":"2026-03-14","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-17-047609","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000120919117047609/doc4.xml","form_type":"4"}},{"id":4243736,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Common Stock","published_at":"2017-08-03T21:14:20.000Z","date":"2017-08-01","kind":"sale","acquired":false,"shares":321,"price":109.35,"value":35101.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.34 to $109.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":49400,"source":{"system":"sec-edgar","filing":"0001209191-17-047609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000120919117047609/doc4.xml","form_type":"4"}},{"id":4243735,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Common Stock","published_at":"2017-08-03T21:14:20.000Z","date":"2017-08-01","kind":"sale","acquired":false,"shares":3771,"price":108.27,"value":408286.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.08 to $108.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":49721,"source":{"system":"sec-edgar","filing":"0001209191-17-047609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000120919117047609/doc4.xml","form_type":"4"}},{"id":4243734,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Common Stock","published_at":"2017-08-03T21:14:20.000Z","date":"2017-08-01","kind":"sale","acquired":false,"shares":5431,"price":107.58,"value":584266.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.08 to $108.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":53492,"source":{"system":"sec-edgar","filing":"0001209191-17-047609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000120919117047609/doc4.xml","form_type":"4"}},{"id":4243733,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Common Stock","published_at":"2017-08-03T21:14:20.000Z","date":"2017-08-01","kind":"sale","acquired":false,"shares":2477,"price":106.85,"value":264667.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.08 to $107.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":58923,"source":{"system":"sec-edgar","filing":"0001209191-17-047609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000120919117047609/doc4.xml","form_type":"4"}},{"id":4243732,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Common Stock","published_at":"2017-08-03T21:14:20.000Z","date":"2017-08-01","kind":"exercise","acquired":true,"shares":3000,"price":44.91,"value":134730.0,"ownership":{"direct":true},"balance_after":61400,"source":{"system":"sec-edgar","filing":"0001209191-17-047609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000120919117047609/doc4.xml","form_type":"4"}},{"id":4511901,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2016-12-27T17:36:05.000Z","date":"2016-12-22","kind":"grant","acquired":true,"shares":30700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest and become exercisable on the first anniversary of the grant date, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":30700,"derivative":{"exercise_price":46.09,"expiration_date":"2026-12-22","underlying":"Common Stock","underlying_shares":30700},"source":{"system":"sec-edgar","filing":"0001209191-16-156837","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000120919116156837/doc4.xml","form_type":"4"}},{"id":4511900,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Common Stock","published_at":"2016-12-27T17:36:05.000Z","date":"2016-12-22","kind":"grant","acquired":true,"shares":8400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":58400,"source":{"system":"sec-edgar","filing":"0001209191-16-156837","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000120919116156837/doc4.xml","form_type":"4"}}]}